Total Funding
61
62
Total FundingSeries D raised
Growth Score 61 in past quarter
-2 pts
Heat Score 62 in past quarter
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
26009
Variantyx is a molecular diagnostics company specializing in advanced genetic testing and diagnostics.
- Haim Neerman: Co-founder and CEOPast Role: Credorax, Chief Operating Officer
- Ludmila Kaplun: Director of Advanced Development
About the Company
Based on clinical whole genome sequencing (WGS) and using a single patient sample, Variantyx's Genomic Unity® test identifies and reports all major variant types including small sequence changes, structural variants, mitochondrial variants and short tandem repeat expansions. This comprehensive test test eliminates the need for traditional
step-wise, reiterative genetic testing.